Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to test two strategies to reduce the risk of contracting Human Immunodeficiency Virus (HIV) or Hepatitis C Virus (HCV) by reducing risk behaviors in patients undergoing drug detoxification.


Clinical Trial Description

n/a


Study Design

Primary Purpose: Prevention


Related Conditions & MeSH terms


NCT number NCT00102349
Study type Interventional
Source National Institute on Drug Abuse (NIDA)
Contact
Status Completed
Phase Phase 3
Start date November 2004
Completion date February 2006

See also
  Status Clinical Trial Phase
Completed NCT03443323 - Organizational Skills Training N/A
Completed NCT02535598 - Therapy Labs: To Improve Adherence in Internet Based Psychotherapy N/A
Completed NCT00084188 - HIV/STD Safer Sex Skills Groups for Women in Drug Treatment Programs - 1 Phase 3
Completed NCT00158288 - The Efficacy of Methadyl Acetate (LAAM) and Contingency Management Procedures for Treating Dual Opioid and Cocaine Abuse - 1 Phase 2
Completed NCT04420533 - Comparative Study Between Behavior Therapy and Behavior Therapy Plus Mirabegron in Sexually Active Men With OAB Symptoms N/A
Recruiting NCT01365026 - PVS: Innovative Programs For Healthy Lifestyle Promotion in Primary Care: 'Prescribe Healthy Life' N/A
Completed NCT03001154 - Virtual Reality Exposure Therapy for Speech Anxiety Using Commercial Hardware and Software N/A
Not yet recruiting NCT06260020 - Development and Validation of a Comprehensive Module for Management of Sleep Disorders in ASD Children N/A
Completed NCT04235582 - Incentives to Decrease Opioid Use - Pilot N/A
Active, not recruiting NCT01318538 - Recovery Group for Women With Substance Use Disorders Phase 2
Completed NCT00084175 - HIV/STD Safer Sex Skills Groups for Men in Drug Treatment Programs - 1 Phase 3